Stay updated on Nivolumab and Metformin in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Metformin in Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab and Metformin in Lung Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe revision tag on the page has been updated from v3.6.0 to v3.6.2, signaling a minor release or patch to the page’s underlying software. This update does not appear to modify the clinical trial details or study information.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedNavigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study). Metadata updates include the investigator name, Last verified, Last known status, and a new revision tag, with older labels removed.SummaryDifference1%

- Check22 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, signaling a new build of the page. This appears to be a maintenance/version update rather than a modification to study content or user-facing features.SummaryDifference0.0%

- Check43 days agoChange DetectedThe study record revision updated to v3.5.4, signaling a minor administrative update to the ClinicalTrials.gov page. This change does not modify the study details or results.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page’s visible revision/version indicator was updated from v3.5.2 to v3.5.3, indicating a change in the ClinicalTrials.gov page revision rather than any study details.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.5.2 added; Revision: v3.5.0 removed.SummaryDifference0.0%

Stay in the know with updates to Nivolumab and Metformin in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Metformin in Lung Cancer Clinical Trial page.